Social enterprise banks on affordable eyeglasses in war against blurry vision

A social enterprise is now banking on a new line of affordable eyeglasses in its war against blurry vision crises across the country.

VisionSpring said the new glasses will play a key role in addressing the rising cases of blurry vision that is currently taking a toll on millions of Kenyans.

Ella Gudwin, the firm's Chief Executive Officer said the initiative is aimed primarily at low-income communities, where access to affordable eye care is limited and the stigma surrounding eyeglasses remains a barrier.

Ella said the new collection offers 29 unique styles in 23 colours, making high-quality eyeglasses accessible at various price points while ensuring affordability for all and including premium options for those seeking more.

Research has shown that wearing eyeglasses not only improves vision but can also increase productivity and income by up to a third, particularly in underserved populations.

According to Ella, in partnership with Lions SightFirst Eye Hospital for the past five years, VisionSpring has already made strides in providing vision screenings and eyeglasses to those in need.

• .

  Keep Reading

• 
  Eyeglasses could boost lifetime earnings by Sh2m
• 
  Giving your children the sex talk
• 
  Refugees in Kakuma at risk of red eye disease infection

While highlighting the importance of offering customers a sense of individuality and dignity through stylish options, she said with the new collection, VisionSpring hopes to create lasting change by making vision correction both accessible and empowering for all.

“Eyeglasses are not just about improving sight; they are an expression of who we are. Our new range is designed to provide every customer with a choice they can feel excited about, regardless of their income,” she stated.

Her sentiments were echoed by Dr Rizwana Peerbhoy, General Manager of Lions SightFirst Eye Hospital who emphasised the critical need for affordable vision care in Kenya.

"This launch will increase demand significantly, addressing the cost barrier many patients face and empowering them with the dignity of choice,” said the GM.